Fundraising Fox

Pini Orbach

Investor

Managing Partner at Arkin Capital

Tel Mond, Center District, Israel

About

Dr. Pini Orbach joined Arkin in 2010 and serves as a Managing Partner overseeing Arkin Bio Ventures and Arkin Bio Capital Funds. He has over 20 years of experience as a drug developer and investor, having incubated and backed multiple biopharmaceutical companies. Previously he was CEO of Optimata Ltd. and CytoD and worked at U.S. firms including Arisaph Pharmaceuticals and Epix Pharmaceuticals; he holds a Ph.D. in Physiology and Functional Genomics from the University of Florida and completed a postdoctoral fellowship at Harvard Medical School.

ContactΒ· self-published, not guessed

Invests in

Biotech

Experience

  1. Arkin CapitalHead of Pharma & Managing Partnercurrent2010 β€” present
  2. NanoDocCEO2010 β€” 2011
  3. Optimata Ltd.CEO2009 β€” 2010
  4. CytoDCEO2008 β€” 2009
  5. Epix PharmaceuticalsDirector and Product Leader2004 β€” 2006

Investments

Investor

BiosightcCAM BiotherapeuticsCense PharmaceuticalsHuman Immunology Biosciences (HiBio)Keros Therapeutics (KROS)Redpin TherapeuticsUroGen Pharma (URGN)

Per the firm's website.

Colleagues at Arkin Capital

Frequently asked questions

Who is Pini Orbach?
Dr. Pini Orbach joined Arkin in 2010 and serves as a Managing Partner overseeing Arkin Bio Ventures and Arkin Bio Capital Funds. He has over 20 years of experience as a drug developer and investor, having incubated and backed multiple biopharmaceutical companies. Previously he was CEO of Optimata Ltd. and CytoD and worked at U.S. firms including Arisaph Pharmaceuticals and Epix Pharmaceuticals; he holds a Ph.D. in Physiology and Functional Genomics from the University of Florida and completed a postdoctoral fellowship at Harvard Medical School.
Where does Pini Orbach work?
Pini Orbach is Managing Partner at Arkin Capital.
What does Pini Orbach invest in?
Pini Orbach invests in Biotech.
What companies has Pini Orbach invested in?
Investments tracked here include Biosight, cCAM Biotherapeutics, Cense Pharmaceuticals, Human Immunology Biosciences (HiBio), Keros Therapeutics (KROS), Redpin Therapeutics, UroGen Pharma (URGN).
Where did Pini Orbach go to school?
Pini Orbach studied at University of Florida College of Medicine (PhD, cardiovascular).

Same school

Shared employers